Reversibel inflammation på injektionsstedet blev observeret i alle grupper (inklusiv kontrolgrupper) og var mere alvorlig i dosisgrupperne med 6 og 20 mg/ kg.
Reversible inflammation at the injection site was noted in all groups (including controls) and was more severe in the 6 and 20 mg/ kg dose groups.